First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Karen Bolhuis et al.|The Lancet Oncology|2023Cited by 168
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trialSusan van der Lei, Karin Nielsen, Anniek M.C. Dooper et al.|The Lancet Oncology|2025Cited by 138
Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial GroupSanne Nieuwenhuizen, Hester J. Scheffer, Robbert S. Puijk et al.|Cancers|2020Cited by 109
MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trialBurak Görgeç, Werner A. Draaisma, Ingrid S Hansen et al.|The Lancet Oncology|2023Cited by 65
Perioperative lipid-enriched enteral nutrition versus standard care in patients undergoing elective colorectal surgery (SANICS II): a multicentre, double-blind, randomised controlled trialEmmeline G. Peters, Misha Luyer, Boudewijn J. J. Smeets et al.|The Lancet. Gastroenterology & hepatology|2018Cited by 45